GeoVax Labs Inc.’s recent filing unveils that its Director CHASE RANDAL D acquired Company’s shares for reported $11000.0 on Sep 21. In the deal valued at $1.10 per share,10,000 shares were bought. As a result of this transaction, CHASE RANDAL D now holds 36,613 shares worth roughly $ 32585.57.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
Then, Sharkey John W. bought 1,000 shares, generating $820 in total proceeds. Upon buying the shares at $0.82, the VP, Business Development now owns 2,860 shares.
Before that, McKee Kelly T. Jr. bought 4,464 shares. GeoVax Labs Inc. shares valued at $5,000 were divested by the Chief Medical Officer at a price of $1.12 per share. As a result of the transaction, McKee Kelly T. Jr. now holds 19,185 shares, worth roughly $17074.65.
Maxim Group initiated its GeoVax Labs Inc. [GOVX] rating to a Buy in a research note published on Friday, November 19, 2020; the price target was $8. PT values the company’s stock at a premium of 88.88 to its Friday closing price.
Price Performance Review of GOVX
On Friday, GeoVax Labs Inc. [NASDAQ:GOVX] saw its stock jump 1.34% to $0.89. On the same session, the stock had its day’s lowest price of $0.8605, but rose to a high of $0.9195. Over the last five days, the stock has lost -9.42%. GeoVax Labs Inc. shares have fallen nearly -75.28% since the year began. Nevertheless, the stocks have fallen -78.18% over the past one year. While a 52-week high of $5.61 was reached on 08/01/22, a 52-week low of $0.55 was recorded on 05/12/22. SMA at 50 days reached $1.0788, while 200 days put it at $1.4184. A total of 0.53 million shares were traded, compared to the trading of 0.56 million shares in the previous session.
Levels Of Support And Resistance For GOVX Stock
The 24-hour chart illustrates a support level at 0.8636, which if violated will result in even more drops to 0.8326. On the upside, there is a resistance level at 0.9226. A further resistance level may holdings at 0.9506. The Relative Strength Index (RSI) on the 14-day chart is 43.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0237, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.88%. Stochastics %K at 26.98% indicates the stock is a holding.
How much short interest is there in GeoVax Labs Inc.?
A steep rise in short interest was recorded in GeoVax Labs Inc. stocks on Jul 14, 2022, dropping by -0.24 million shares to a total of 0.1 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 0.34 million shares. There was a decline of -238.57%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.82% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.05.
GeoVax Labs Inc. [GOVX] – Who Are The Largest Shareholders?
In filings from Armistice Capital LLC, it is revealed that the company now owns 1,358,439 shares, or roughly 5.49% of the outstanding GOVX shares. In other words, the investor’s shares have risen by 923,289 from its previous 13-F filing of 435150.0. Over the last quarter, Two Sigma Investments LP purchased 98,155 shares of GeoVax Labs Inc., while Virtu Financial BD LLC bought 19,409 shares. At present, Tower Research Capital LLC is holding 61,386 shares valued at $66911.0. Geode Capital Management LLC owned 54,842 shares of the company at the time of its most recent 13F filing, worth $59778.0.
According to FactSet, GeoVax Labs Inc.’s share price will average $8.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 809.09 percent from its previous closing price of $0.88. Analysts expect GeoVax Labs Inc. stock to reach the higher price of $8.00, while the lowest price estimate is $8.00. However, 1 analyst have rated GOVX stock as a Buy in their predictions for 2022.